Myocardial contrast echocardiography in acute myocardial infarction

American Journal of Cardiology

Volumn 90, Issue 10 SUPPL. 1, 2002, Pages 38-47

  Villanueva, Flordeliza S ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; COLLATERAL CIRCULATION; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; HEART VENTRICLE REMODELING; HUMAN; MICROVASCULATURE; MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY; NECROSIS; NUTRITION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0037131953     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02947-8     Document Type: Article

References (43)

1. TIMI Study Group . The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 312:1985;932-936.
2. Schomig A., Kastrati A., Dirschinger J., Mehilli J., Schricke U., Pache J., Martinoff S., Neumann F.J., Schwaiger M., Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators . Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarctoin. N Engl J Med. 343:2000;385-391.
3. Grines C.L., Cox D.A., Stone G.W., Garcia E., Mattos L.A., Giambartolomei A., Brodie B.R., Madonna O., Eijgelshoven M., Lansky A.J., O'Neill W.W., Morice M.C., Stent Primary Angioplasty in Myocardial Infarction Study Group . Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 341:1999;1949-1956.
4. Gibson C.M., Cannon C.P., Murphy S.A., Adgey A.A., Schweiger M.J., Sequeira R.F., Grollier G., Fox N.L., Berioli S., Weaver W.D., Van de Werf F., Braunwald E., TIMI 10B Investigators . Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the Thrombolysis in Myocardial Infarction 10B trial. Am J Cardiol. 84:1999;976-980.
5. Zijlstra F., Hoorntje J.C., de Boer M.J., Reiffers S., Miedema K., Ottervanger J.P., van'T Hof A.W., Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 341:1999;1413-1419.
6. Puma J.A., Sketch M.H. Jr, Thompson T.D., Simes R.J., Morris D.C., White H.D., Topol E.J., Califf R.M. Support for the open-artery hypothesis in survivors of acute myocardial infarction analysis of 11,228 patients treated with thrombolytic therapy . Am J Cardiol. 83:1999;482-487.
7. Hudson M.P., Granger C.B., Topol E.J., Pieper K.S., Armstrong P.W., Barbash G.I., Guerci A.D., Vahanian A., Califf R.M., Ohman E.M. Early reinfarction after fibrinolysis experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials . Circulation. 104:2001;1229-1235.
8. Topol E.J., Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 101:2000;570-580.
9. Kemper A.J., O'Boyle J.E., Cohen C.A., Taylor A., Parisi A.F. Hydrogen peroxide contrast echocardiography quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion . Circulation. 70:1984;309-317.
10. Kaul S., Gillam L.D., Weyman A.E. Contrast echocardiography in acute myocardial ischemia. II. The effect of site of injection of contrast agent on the estimation of area at risk for necrosis after coronary occlusion. J Am Coll Cardiol. 6:1985;825-830.
11. Kaul S., Glasheen W., Ruddy T.D., Pandian N.G., Weyman A.E., Okada R.D. The importance of defining left ventricular area at risk in vivo during acute myocardial infarction an experimental evaluation with myocardial contrast two-dimensionalechocardiography . Circulation. 75:1987;1249-1260.
12. Villanueva F.S., Glasheen W.P., Sklenar J., Kaul S. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Circulation. 88:1993;596-604.
13. Reimer K.A., Jennings R.B. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 40:1979;633-644.
14. Coggins M.P., Sklenar J., Le D.E., Wei K., Lindner J.R., Kaul S. Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation. 104:2001;2471-2477.
15. Cobb F.R., Bache R.J., Rivas F., Greenfield J.C. Jr. Local effects of acute cellular injury on regional myocardial blood flow. J Clin Invest. 57:1976;1359-1368.
16. Kloner R.A., Ganote C.E., Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 54:1974;1496-1508.
17. Johnson W.B., Malone S.A., Pantely G.A., Anselone C.G., Bristow J.D. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation. 78:1988;462-472.
18. Braunwald E., Kloner R.A. The stunned myocardium prolonged, postischemic ventricular dysfunction . Circulation. 66:1982;1146-1149.
19. Cooper H.A., Braunwald E. Clinical importance of stunned and hibernating myocardium. Coron Artery Dis. 12:2001;387-392.
20. Villanueva F.S., Glasheen W.P., Sklenar J., Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining extent of myocardial salvage. Circulation. 88:1993;2596-2606.
21. Ito H., Tomooka T., Sakai N., Yu H., Higashino Y., Fujii K., Masuyama T., Kitabatake A., Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis. A prediction of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 85:1992;1699-1705.
22. Ragosta M., Camarano G., Kaul S., Powers E.R., Sarembock I.J., Gimple L.W. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation. 89:1994;2562-2569.
23. Rocchi G., Kasprzak J.D., Galema T.W., de Jong N., Ten Cate F.J. Usefulness of power Doppler contrast echocardiography to identify reperfusion after acute myocardial infarction. Am J Cardiol. 87:2001;278-282.
24. Ito H., Iwakura K., Oh H., Masuyama T., Hori M., Higashino Y., Fujii K., Minamino T. Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability. Circulation. 91:1995;656-662.
25. Asanuma T., Tanabe K., Ochiai K., Yoshitomi H., Nakamura K., Murakami Y., Sano K., Shimada T., Murakami R., Morioka S., Beppu S. Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction myocardial contrast echocardiographic study . Circulation. 96:1997;448-453.
26. Kamp O., Lepper W., Vanoverschelde J.L., Aeschbacher B.C., Rovai D., Assayag P., Voci P., Kloster Y., Distante A., Visser C.A. Serial evaluation of perfusion defects in patients with a first acute myocardial infarction referred for primary PTCA using intravenous myocardial contrast echocardiography. Eur Heart J. 22:2001;1485-1495.
27. Main M.L., Magalski A., Chee N.K., Coen M.M., Skolnick D.G., Good T.H. Full-motion pulse inversion power Doppler contrast echocardiography differentiates stunning from necrosis and predicts recovery of left ventricular function after acute myocardial infarction. J Am Coll Cardiol. 38:2001;1390-1394.
28. Ito H., Maruyama A., Iwakura K., Takiuchi S., Masuyama T., Hori M., Higashino Y., Fujii K., Minamino T. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 93:1996;223-228.
29. Iwakura K., Ito H., Kawano S., Shintani Y., Yamamoto K., Kato A., Ikushima M., Tanaka K., Kitakaze M., Hori M., Higashino Y., Fujii K. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol. 38:2001;472-477.
30. Ito H., Okamura A., Iwakura K., Masuyama T., Hori M., Takiuchi S., Negoro S., Nakatsuchi Y., Taniyama Y., Higashino Y., Fujii K., Minamino T. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 93:1996;1993-1999.
31. Lepper W., Sieswerda G.T., Vanoverschelde J.L., Franke A., de Cock C.C., Kamp O., Kuhl H.P., Pasquet A., Voci P., Visser C.A., Hanrath P., Hoffmann R. Predictive value of markers of myocardial reperfusion in acute myocardial infarction for follow-up left ventricular function. Am J Cardiol. 88:2001;1358-1363.
32. Jayaweera A.R., Wei K., Coggins M., Bin J.P., Goodman C., Kaul S. Role of capillaries in determining CBF reserve new insights using myocardial contrast echocardiography . Am J Physiol. 277:1999;H2363-H2372.
33. Lepper W., Hoffmann R., Kamp O., Franke A., de Cock C.C., Kuhl H.P., Sieswerda G.T., Dahl J., Janssens U., Voci P., Visser C.A., Hanrath P. Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. [correction of angiography] Circulation. 101:2000;2368-2374.
34. Wei K., Jayaweera A.R., Firoozan S., Linka A., Skyba D.M., Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of micro- bubbles administered as a constant venous infusion. Circulation. 97:1998;473-483.
35. Swinburn J.M., Lahiri A., Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. J Am Coll Cardiol. 38:2001;19-25.
36. Lindner J.R., Villanueva F.S., Dent J.M., Wei K., Sklenar J., Kaul S. Assessment of resting perfusion with myocardial contrast echocardiography theoretical and practical considerations . Am Heart J. 139:2000;231-240.
37. Villanueva F.S., Gertz E.W., Csikari M., Pulido G., Fisher D., Sklenar J. Detection of coronary artery stenosis with power Doppler imaging. Circulation. 103:2001;2624-2630.
38. Basude R., Wheatley M.A. Generation of ultraharmonics in surfactant based ultrasound contrast agents use and advantages . Ultrasonics. 39:2001;437-444.
39. Taniyama Y., Ito H., Iwakura K., Masuyama T., Hori M., Takiuchi S., Nishikawa N., Higashino Y., Fujii K., Minamino T. Beneficial effect of intracoronary vera-pamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol. 30:1997;1193-1199.
40. Ito H., Taniyama Y., Iwakura K., Nishikawa N., Masuyama T., Kuzuya T., Hori M., Higashino Y., Fujii K., Minamino T. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 33:1999;654-660.
41. Taniyama Y., Ito H., Morishita R., Ogihara T. Potential of microvascular reperfusion with adjunctive pharmacological intervention its impact on myocardial perfusion and functional outcomes in patients with acute myocardial infarction . Drugs. 61:2001;437-441.
42. Sakuma T., Wei K., Rim S.-J., Leong-Poi H., Fisher N., Kaul S. Distal microthromboembolism contributes to the no flow phenomenon after primary PTCA in acute myocardial infarction [abstract]. J Am Coll Cardiol. 37:2001;397A.
43. Gassler J.P., Topol E.J. Reperfusion revisited: beyond TIMI 3 flow. Clin Cardiol. 22:1999;IV20-IV29.